Average Insider

Where insiders trade, we follow

$ELVN
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Healthcare
Sector
Biotechnology
Industry
Richard A. Fair
CEO
62
Employees
$44.83
Current Price
$1.55B
Market Cap
52W Low$14.79
Current$44.8363.2% above low, 36.8% below high
52W High$62.32

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00--All Sells
Sells22$423,887.5611,018
2 monthsBuys00--All Sells
Sells33$1,030,606.6624,018
3 monthsBuys00--All Sells
Sells39$1,585,363.5435,036
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Oct 19, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale6,018$38.48$231,545.56View Details
Oct 19, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale5,000$38.47$192,342.00View Details
Oct 1, 2026
Garland J. Scott
Director
Sale13,000$46.67$606,719.10View Details
Sep 17, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale289$51.49$14,881.45View Details
Sep 17, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale3,535$50.03$176,851.10View Details
Sep 17, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale2,194$50.72$111,270.47View Details
Sep 17, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale1,844$50.71$93,507.21View Details
Sep 17, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale240$51.48$12,355.68View Details
Sep 17, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale2,916$50.03$145,890.98View Details
Aug 17, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale4,630$58.35$270,168.37View Details
Aug 17, 2026
Hohl Benjamin
CHIEF FINANCIAL OFFICER
Sale1,388$59.35$82,382.80View Details
Aug 17, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale1,100$59.35$65,281.15View Details
Aug 17, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Sale3,900$58.37$227,649.63View Details
61 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 11, 2026
EPS
Estimated-$0.45
ActualN/A
Revenue
EstimatedN/A
ActualN/A
2 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.10.12